KVUE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.12% compare to its pairs and should correct upwards.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health...

Stats
Šios dienos apimtis	15.79M
Vidutinė apimtis	21.07M
Rinkos kapitalizacija	34.81B
EPS	$0.150 ( Q1 \| 2024-05-09 )
Kita pelno data	( $0.290 ) 2024-07-18
Last Dividend	$0.200 ( 2024-05-07 )
Next Dividend	$0 ( N/A )
P/E	23.31 (Sector) 23.61 (Industry) 29.43
ATR14	$0.0160 (0.09%)

CHD -0.32%

CL -1.15%

CLX -0.10%

COTY -0.20%

EL -4.02%

ELF -3.34%

EPC -0.72%

GROV 1.14%

HIMS 0.85%

KMB -0.83%

KVUE -1.30%

NTCO 0.38%

NUS -2.41%

PG -1.02%

REV 0.00%

SPB 0.46%

UL -0.65%

Insider Trading

Date	Person	Action	Amount	type
2024-06-03	Dyer Russell	Buy	68 389	Stock Options
2024-06-03	Dyer Russell	Buy	7 796	Restricted Stock Units
2024-05-23	Sneed Michael E	Buy	9 259	Deferred Share Units
2024-05-23	Godbole Seemantini	Buy	9 259	Deferred Share Units
2024-05-23	Wolk Joseph J	Buy	9 259	Deferred Share Units

INSIDER POWER
92.80
Last 48 transactions
Buy: 4 070 359 \| Sell: 118 295

Koreliacija (AI algo v.1.1b): Undervalued: 0.12% $18.21 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.32 (neutral)

Trumpas: 0.57 (weak)

Signal:(65.519) Neutral

Kenvue Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
TAFM	0.852
RLTY	0.848
STXT	0.838
RSPH	0.831
VSHY	0.828
DMA	0.827
MTBA	0.824
RSPC	0.814
QVOY	0.811
DFGR	0.81

10 Labiausiai neigiamai susiję koreliacijos
ULS	-0.818
HAFN	-0.807

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Kenvue Inc. Koreliacija - Valiuta/Žaliavos

0.14
( neutral )

0.02
( neutral )

0.00
( neutral )

0.44
( neutral )

0.00
( neutral )

-0.17
( neutral )

Kenvue Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$15.44B
Bruto pelnas:	$8.61B (55.77 %)
EPS:	$0.870

FY	2023
Pajamos:	$15.44B
Bruto pelnas:	$8.61B (55.77 %)
EPS:	$0.870

FY	2022
Pajamos:	$14.95B
Bruto pelnas:	$8.29B (55.42 %)
EPS:	$1.080

Financial Reports:

No articles found.

Kenvue Inc. Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)

Kenvue Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.33 - Increase likely (46.51%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.200	2023-08-25
Last Dividend	$0.200	2024-05-07
Next Dividend	$0	N/A
Payout Date	2024-05-22
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	$0.800	--
Avg. Dividend % Per Year	1.73%	--
Score	4.9	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.33
Div. Directional Score	8.88	--

Next Divdend (Est)
(2024-07-02)

$0.202 Estimate 40.00 %

Dividend Stability

0.80 Very Good

Dividend Score

4.90

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2023	$0.400	1.49%
2024	$0.400	1.85%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
07 May 2024	$0.200	25 Apr 2024	08 May 2024	22 May 2024
13 Feb 2024	$0.200	25 Jan 2024	14 Feb 2024	28 Feb 2024
07 Nov 2023	$0.200	26 Oct 2023	08 Dec 2023	22 Nov 2023
25 Aug 2023	$0.200	20 Jul 2023	28 Aug 2023	07 Sep 2023

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ECC	Dividend Diamond	2024-07-11	Monthly	11	14.91%	9.72
BRW	Dividend Diamond	2024-06-11	Monthly	33	9.41%	9.26
VVR	Dividend Diamond	2024-06-18	Monthly	27	8.85%	9.19
FCT	Dividend Diamond	2024-06-03	Monthly	21	8.33%	9.14
PHK	Dividend Diamond	2024-06-13	Monthly	22	9.07%	9.13
SBR	Dividend Diamond	2024-06-17	Monthly	38	9.57%	9.10
XFLT	Dividend Diamond	2024-06-17	Monthly	8	10.49%	9.09
SRV	Dividend Royal	2024-07-16	Monthly	18	10.61%	9.04
FAM	Dividend Royal	2024-06-03	Monthly	20	8.07%	8.98
RA	Dividend Diamond	2024-06-11	Monthly	9	10.10%	8.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0963	1.500	8.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0546	1.200	8.18	9.81	[0 - 0.3]
returnOnEquityTTM	0.136	1.500	9.60	10.00	[0.1 - 1]
payoutRatioTTM	0.514	-1.000	4.86	-4.86	[0 - 1]
currentRatioTTM	0.989	0.800	-0.0560	-0.0448	[1 - 3]
quickRatioTTM	0.538	0.800	-1.543	-1.235	[0.8 - 2.5]
cashRatioTTM	0.187	1.500	-0.0705	-0.106	[0.2 - 2]
debtRatioTTM	0.315	-1.500	4.75	-7.12	[0 - 0.6]
interestCoverageTTM	7.57	1.000	8.31	8.31	[3 - 30]
operatingCashFlowPerShareTTM	1.385	2.00	9.54	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.089	2.00	9.46	10.00	[0 - 20]
debtEquityRatioTTM	0.810	-1.500	6.76	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.566	1.000	3.91	3.91	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.64	8.64	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.309	1.000	9.40	9.40	[0.2 - 2]
assetTurnoverTTM	0.568	0.800	9.55	7.64	[0.5 - 2]
Total Score				10.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	23.35	1.000	7.74	0	[1 - 100]
returnOnEquityTTM	0.136	2.50	9.74	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.089	2.00	9.64	10.00	[0 - 30]
dividendYielPercentageTTM	4.40	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.385	2.00	9.54	10.00	[0 - 30]
payoutRatioTTM	0.514	1.500	4.86	-4.86	[0 - 1]
pegRatioTTM	14.29	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.22	0	[0.1 - 0.5]
Total Score				7.33

Kenvue Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Kenvue Inc.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women\'s health, and wound care products under the Listerine, Johnson\'s, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.